机构:[1]Shanghai Institute of Immunology, State Key Laboratory of Oncogenes and RelatedGenes, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China[2]Shanghai Jiao Tong University School of Medicine–Yale Institute for ImmuneMetabolism, Shanghai Jiao Tong University School of Medicine, Shanghai 200025,China[3]Department of Pediatrics and Key Laboratory of Birth Defects and RelatedDiseases of Women and Children of MOE, West China Second University Hospital,Sichuan University, China[4]Hefei National Laboratory for Physical Sciences at Microscale,the Chinese Academy of Sciences Key Laboratory of Innate Immunityand Chronic Disease, School of Basic Medical Sciences, Division of Life Sciencesand Medicine, University of Science and Technology of China, 230027 Hefei,China[5]Institute for Advanced Studies, State Key Laboratory of Virology, College ofLife Sciences, Wuhan University, Wuhan 430072, China[6]State Key Laboratory ofMolecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center forExcellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai200031, China[7]University of Chinese Academy of Sciences, Beijing 100049, China[8]School of Life Sciences, Peking University, Beijing 100871, China[9]Department ofLiver Surgery and State Key Laboratory of Oncogenes and Related Genes, Ren JiHospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127,China[10]Department of Immunobiology, Yale University School of Medicine,New Haven, CT 06520-8055, USA[11]Howard Hughes Medical Institute, Yale UniversitySchool of Medicine, New Haven, CT 06520-8055, USA
This work was supported by the
National Natural Science Foundation of China (91753141/82030042/32070917 to H.-B.L.,
81822021/91842105 to S.Z., 81801550 to J.T., and 81901580 to Y.L.), the Shanghai Science and
Technology Committee (grant no. 20JC1417400/201409005500/20JC1410100 to H.-B.L.), the
Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of
Higher Learning (to H.-B.L.), the start-up fund from the Shanghai Jiao Tong University School
of Medicine (to H.-B.L.), the National Key R&D Program of China (2018YFA0508000) (to S.Z.),
the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29030101)
(to S.Z.), and the Howard Hughes Medical Institute (to R.A.F.).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|1 区综合性期刊
小类|1 区综合性期刊
最新[2023]版:
大类|1 区综合性期刊
小类|1 区综合性期刊
第一作者:
第一作者机构:[1]Shanghai Institute of Immunology, State Key Laboratory of Oncogenes and RelatedGenes, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China[2]Shanghai Jiao Tong University School of Medicine–Yale Institute for ImmuneMetabolism, Shanghai Jiao Tong University School of Medicine, Shanghai 200025,China[3]Department of Pediatrics and Key Laboratory of Birth Defects and RelatedDiseases of Women and Children of MOE, West China Second University Hospital,Sichuan University, China
共同第一作者:
通讯作者:
通讯机构:[1]Shanghai Institute of Immunology, State Key Laboratory of Oncogenes and RelatedGenes, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China[2]Shanghai Jiao Tong University School of Medicine–Yale Institute for ImmuneMetabolism, Shanghai Jiao Tong University School of Medicine, Shanghai 200025,China[9]Department ofLiver Surgery and State Key Laboratory of Oncogenes and Related Genes, Ren JiHospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127,China[10]Department of Immunobiology, Yale University School of Medicine,New Haven, CT 06520-8055, USA[11]Howard Hughes Medical Institute, Yale UniversitySchool of Medicine, New Haven, CT 06520-8055, USA
推荐引用方式(GB/T 7714):
Tong Jiyu,Wang Xuefei,Liu Yongbo,et al.Pooled CRISPR screening identifies m6A as a positive regulator of macrophage activation.[J].Science advances.2021,7(18):doi:10.1126/sciadv.abd4742.
APA:
Tong Jiyu,Wang Xuefei,Liu Yongbo,Ren Xingxing,Wang Anmin...&Li Hua-Bing.(2021).Pooled CRISPR screening identifies m6A as a positive regulator of macrophage activation..Science advances,7,(18)
MLA:
Tong Jiyu,et al."Pooled CRISPR screening identifies m6A as a positive regulator of macrophage activation.".Science advances 7..18(2021)